AVECTAS
LIVE

Serial Number

98141953

Owner

AVECTAS LIMITED

Attorney

Susan Neuberger Weller

Filing Date

Aug 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

AVECTAS Trademark

Serial Number: 98141953 • Registration: 7473486

AVECTAS is a trademark filed by AVECTAS LIMITED on August 21, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AVECTAS LIMITED (6 trademarks)

34 FITZWILLIAM SQUARE
SOUTH DUBLIN 2 , IE

Entity Type: 99

Trademark Details

Filing Date

August 21, 2023

Registration Date

August 13, 2024

Published for Opposition

May 28, 2024

Goods & Services

Scientific apparatus and instruments, namely, scientific apparatus and instruments for the transfer of biological molecules into living cells; measuring apparatus and instruments, namely, pressure measuring apparatus; probes for scientific purposes, namely, ultrasound probes, not for medical use; bioassay apparatus, namely, pressure measuring apparatus for use in bioassay techniques other than medical; replacement parts and fittings for the aforesaid goods

Pharmaceutical preparations for the treatment of immune-oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; stem cells for medical purposes; living cells for medical use

Stem cells for research purposes

Surgical apparatus and instruments; medical apparatus and instruments for delivery of macro molecules to the mouth, nose, airway, lungs; veterinary apparatus and instruments, namely, catheter for veterinary purposes; medical and surgical probes; probes for medical use and medical diagnostic purposes; medical heartbeat measuring apparatus for use in bioassay techniques; replacement parts and fittings for the aforesaid goods; measuring apparatus and instruments, namely, heartbeat measuring apparatus

Scientific and technological services, namely, research and design in the field of pharmaceutics, tissue engineering and regenerative medicine; analysis of industrial fluids and scientific research services; medical and scientific research; pharmaceutical research and development, and clinical testing, namely, conducting clinical trials for others in the field of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of probes, reagents and bioassays for industrial and scientific purposes; advisory, consultancy and information services relating to the provision of the aforesaid

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 13, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 13, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 22, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 22, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 22, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 22, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 20, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 20, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 20, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 19, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 20, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 19, 2023 NWOS
NEW APPLICATION ENTERED
Aug 25, 2023 NWAP